MAC
Mason & Associates (California) Portfolio holdings
AUM
$531M
1-Year Est. Return
19.08%
This Fund
S&P 500
1 Year Est. Return
+19.08%
AUM
$531M
AUM Growth
+$34.8M
(+7%)
Holding
167
Top Buys
| 1 | +$61.7M | |
| 2 | +$14.3M | |
| 3 | +$5.75M | |
| 4 |
BlackRock ESG Capital Allocation Term Trust
ECAT
|
+$5.49M |
| 5 |
Pacer US Large Cap Cash Cows Growth Leaders ETF
COWG
|
+$3.71M |
Top Sells
| 1 | +$86.9M | |
| 2 | +$14.9M | |
| 3 | +$3.17M | |
| 4 |
Dimensional US Equity ETF
DFUS
|
+$646K |
| 5 |
NYLI FTSE International Equity Currency Neutral ETF
HFXI
|
+$609K |
Sector Composition
| 1 | Technology | 9.43% |
| 2 | Financials | 3.69% |
| 3 | Communication Services | 2.8% |
| 4 | Consumer Discretionary | 2.73% |
| 5 | Healthcare | 1.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Cencora
COR
$67.3B
| $216K | 0.04% |
+640
|
|
||
152
Johnson & Johnson
JNJ
$586B
| $211K | 0.04% |
1,018
-168
|
|
||
153
Intuitive Surgical
ISRG
$172B
| $210K | 0.04% |
+370
|
|
||
154
AT&T
T
$194B
| $203K | 0.04% |
+8,186
|
|
||
155
Geron
GERN
$1.06B
| $159K | 0.03% |
+120,700
|
|
||
156
Recursion Pharmaceuticals
RXRX
$1.79B
| $136K | 0.03% |
33,165
|
|
||
|
IBO
157
Impact BioMedical
IBO
$45.9M
| $5.05K | ﹤0.01% |
10,000
|
|
||
158
Biogen
BIIB
$26.9B
| – | – |
-1,563
|
|
||
159
Corebridge Financial
CRBG
$11.4B
| – | – |
-6,278
|
|
||
160
Dell
DELL
$104B
| – | – |
-2,595
|
|
||
161
iShares US Aerospace & Defense ETF
ITA
$16B
| – | – |
-1,566
|
|
||
162
JPMorgan US Quality Factor ETF
JQUA
$6.96B
| – | – |
-1,381,590
|
|
||
163
Mobileye
MBLY
$6.68B
| – | – |
-15,400
|
|
||
164
Nuveen ESG International Developed Markets Equity ETF
NUDM
$636M
| – | – |
-5,340
|
|
||
165
Southern Company
SO
$111B
| – | – |
-2,211
|
|
||
|
ETHW
166
Bitwise Ethereum ETF
ETHW
$268M
| – | – |
-13,345
|
|
||
167
iShares Agency Bond ETF
AGZ
$566M
| – | – |
-134,573
|
|